Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Perfusion
|
May 19, 2025
Integrated pipeline for minimally invasive extracorporeal circulation: A basic experimental study
Chengxiu Zhao, Yuheng Lang, Yanying Wang, et al.
Annals of Clinical Microbiology and Antimicrobials
|
November 6, 2022
Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations
Wei Wang, Shanshan Li, Qiping Ge, et al.
BMC Cancer
|
January 17, 2024
Clinical study of thoracoscopic assisted different surgical approaches for early thymoma: a meta-analysis
Jincheng Wang, Ti Tong, Kun Zhang, et al.
Antimicrobial Resistance and Infection Control
|
August 27, 2021
Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition
Cong Yao, Haiping Guo, Qiang Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 17, 2026
Controlled Moderate Interfacial Reaction Facilitates High-Strength Low-Resistivity Barrier Layer for Half-Heusler Thermoelectrics
Jian Liang, Shuyue Tan, Lifeng Jiang, et al.
Journal of Infection and Public Health
|
June 4, 2023
Transmission and resistome of extremely drug-resistant tuberculosis in Beijing, China: A retrospective population-based epidemiological study
Haiping Guo, Jun An, Shanshan Li, et al.
Infection and Drug Resistance
|
August 25, 2022
A Peptidomic Approach to Identify Novel Antigen Biomarkers for the Diagnosis of Tuberculosis
Hongmei Chen, Shanshan Li, Weijie Zhao, et al.
Plos One
|
November 10, 2012
L-carnitine is an endogenous HDAC inhibitor selectively inhibiting cancer cell growth in vivo and in vitro
Hongbiao Huang, Ningning Liu, Haiping Guo, et al.
Cancer Letters
|
January 11, 2011
Gambogic acid enhances proteasome inhibitor-induced anticancer activity
Hongbiao Huang, Di Chen, Shujue Li, et al.
Plos One
|
January 4, 2013
HDAC inhibitor L-carnitine and proteasome inhibitor bortezomib synergistically exert anti-tumor activity in vitro and in vivo
Hongbiao Huang, Ningning Liu, Changshan Yang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Perfusion
|
May 19, 2025
Integrated pipeline for minimally invasive extracorporeal circulation: A basic experimental study
Chengxiu Zhao, Yuheng Lang, Yanying Wang, et al.
Annals of Clinical Microbiology and Antimicrobials
|
November 6, 2022
Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations
Wei Wang, Shanshan Li, Qiping Ge, et al.
BMC Cancer
|
January 17, 2024
Clinical study of thoracoscopic assisted different surgical approaches for early thymoma: a meta-analysis
Jincheng Wang, Ti Tong, Kun Zhang, et al.
Antimicrobial Resistance and Infection Control
|
August 27, 2021
Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition
Cong Yao, Haiping Guo, Qiang Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 17, 2026
Controlled Moderate Interfacial Reaction Facilitates High-Strength Low-Resistivity Barrier Layer for Half-Heusler Thermoelectrics
Jian Liang, Shuyue Tan, Lifeng Jiang, et al.
Journal of Infection and Public Health
|
June 4, 2023
Transmission and resistome of extremely drug-resistant tuberculosis in Beijing, China: A retrospective population-based epidemiological study
Haiping Guo, Jun An, Shanshan Li, et al.
Infection and Drug Resistance
|
August 25, 2022
A Peptidomic Approach to Identify Novel Antigen Biomarkers for the Diagnosis of Tuberculosis
Hongmei Chen, Shanshan Li, Weijie Zhao, et al.
Plos One
|
November 10, 2012
L-carnitine is an endogenous HDAC inhibitor selectively inhibiting cancer cell growth in vivo and in vitro
Hongbiao Huang, Ningning Liu, Haiping Guo, et al.
Cancer Letters
|
January 11, 2011
Gambogic acid enhances proteasome inhibitor-induced anticancer activity
Hongbiao Huang, Di Chen, Shujue Li, et al.
Plos One
|
January 4, 2013
HDAC inhibitor L-carnitine and proteasome inhibitor bortezomib synergistically exert anti-tumor activity in vitro and in vivo
Hongbiao Huang, Ningning Liu, Changshan Yang, et al.
Page
of 3